Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03150576
Title Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer (PARTNER)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cambridge University Hospitals NHS Foundation Trust
Age Groups: senior | adult | child
Covered Countries GBR

No variant requirements are available.